24 C
Dubai

Christina Applegate Investigates Breast Implants Linking to Pain

Must read

Christina Applegate, 54, has stated that she is investigating a potential connection between her breast implants and her persistent pain and fatigue, following her recent revelation of being misdiagnosed with multiple sclerosis (MS) in 2021.

During the November 10 episode of MeSsy, the podcast she co-hosts alongside Jamie-Lynn Sigler, Applegate, known for her role as a teenager in the popular sitcom Married With Children, mentioned that she received a study indicating that symptoms linked to breast implants could mimic those of MS.

“For the past five years or so, I’ve often thought, ‘What if they’re leaking and poisoning me?'” she shared, expressing her intention to address this concern with her healthcare providers.

In 2008, Applegate underwent a double mastectomy and subsequent breast reconstruction after being diagnosed with an early stage of breast cancer and identified as carrying a BRCA1 gene mutation, which increases the risk for breast and other cancers. She acknowledged on her podcast that she is “way overdue” for a replacement of her implants.

She has also reported experiencing increasing pain and mobility issues with her right shoulder, indicating that it can take her at least 10 minutes to sit up and leave her bed. The multitude of symptoms is overwhelming, she noted, as “there are so many different factors that could be at play.”

Her inquiry into the matter follows a recent confirmation from doctors that she does not have MS. Applegate shared that this revelation left her feeling as if she was back at “Square 1,” and despite her ongoing challenges, she is currently being evaluated for other potential conditions such as rheumatoid arthritis, lupus, and Lyme disease.

While the origin of Applegate’s symptoms remains unclear, there have been instances where breast implants have been linked to various illnesses, though the underlying condition is not yet fully understood.

What is known about breast implant illness

As connections between breast implants and autoimmune diseases become clearer, women with breast implant illness urge doctors to warn others of the risks. Unknown hands hold a Biocell textured breast implant by Allergan.

Breast implant illness, or BII, refers to symptoms reported by some individuals with implants, which may include fatigue, cognitive changes, joint pain, and muscle pain. This image displays a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)

Breast implant illness, commonly abbreviated as BII, describes a range of symptoms reported by some individuals who have implants.

As of December 31, 2025, Health Canada had documented 663 instances of symptoms or diseases linked to breast implants, translating to approximately one report for every 1,025 implants sold in Canada.

The most frequently mentioned symptom was fatigue, followed by mood changes, gastrointestinal issues, and cognitive alterations. It’s important to note that these are reports and not confirmed cases; Health Canada emphasizes that the existing data does not definitively establish that implants are the cause of these symptoms, as they could be attributed to other factors.

The U.S. Food and Drug Administration (FDA) indicates that BII is not recognized as a formal medical diagnosis and lacks a specific test for identification. Reports of symptoms such as fatigue and joint pain do not clarify how common these issues are or if they are implant-related.

Julie Elliott, a patient advocate, licensed practical nurse (LPN), and Canadian representative for the Breast Implant Safety Alliance (BISA), who claims she has been diagnosed with autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) due to her breast implants, shared with CBC News that numerous symptoms reported by individuals with implants can overlap with those of MS.

“Chronic fatigue, memory changes, concentration issues, numbness, tingling, nerve pain, muscle weakness, hair loss, and more — these are indeed similar to MS symptoms,” Elliott noted.

However, she cautioned against hastily concluding that Applegate’s implants are to blame. “I’m not suggesting that Christina Applegate’s breast implants are the cause of her symptoms,” she added, warning that it would be “premature and irresponsible” to make such assumptions.

“Similar symptoms do not equate to the same diagnosis,” Elliott explained. “Every possibility must be thoroughly explored and not dismissed without proper medical examination.”

A woman in a large black dress and carrying a black cane, poses on a red carpet.

Christina Applegate, left, arrives for the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)

Dr. Stephen Nicolaidis, a plastic surgeon based in Montreal who has treated over 1,500 patients for implant removals, also stressed the importance of ruling out other potential causes.

He referred to BII as a “diagnosis of exclusion,” explaining that patients must undergo thorough evaluations, and only if no alternative causes are identified should the possibility of implants contributing to the issues be considered.

Nicolaidis noted that common symptoms he frequently encounters include fatigue, hair loss, skin rashes, breathing difficulties, joint and muscle pain, sleep disturbances, and cognitive fog. Some of these may overlap with symptoms linked to autoimmune diseases.

Regarding the symptoms described by Applegate, he remarked, “The symptoms she experiences could certainly be linked to her breast implants.” However, he reiterated that the precise cause of BII remains unclear, and researchers have yet to provide conclusive insights into how implants may contribute to these symptoms.

Nicolaidis mentioned that there is no specific test available to diagnose BII. While imaging may reveal silicone outside of an implant, he pointed out that such findings are not necessary for someone to report symptoms. He also clarified that BII is distinct from implant-associated lymphoma, a cancer associated with certain textured implants.

Rupture, removal, and next steps

A rupture or leak is a separate issue from BII. The FDA identifies rupture and deflation as potential complications of implants and recommends that patients consult their healthcare provider regarding any new or unusual breast changes.

Likewise, Health Canada advises individuals with implants to regularly monitor for abnormal breast changes and discuss any signs or symptoms with their doctor. Decisions concerning the retention, replacement, or removal of implants should be made collaboratively with a clinician, considering individual symptoms, potential causes, and surgical risks, according to the agency.

Preventive removal of implants is not recommended due to the associated surgical risks, and patients are encouraged to discuss any symptoms they experience with their healthcare provider.

Nicolaidis recommended that individuals experiencing symptoms seek a comprehensive medical evaluation. If other potential causes are ruled out, they can discuss whether their implants might be a contributing factor and explore options with their healthcare providers.

He ceased placing breast implants in 2021, believing that the risks often outweighed the benefits, and now primarily focuses on implant removals. He cautioned that removal does not guarantee a complete resolution of symptoms, noting that some patients he has treated for MS reported only marginal improvement, and those with diagnosed autoimmune diseases may still require medical treatment post-removal, known as explant surgery.

Elliott asserted that symptoms associated with implants should be taken seriously, while recognizing that their causes remain inadequately understood. She urged patients to seek balanced, evidence-informed information and to monitor any health changes.

“The absence of complete answers does not mean that women’s experiences should be disregarded,” she emphasized.

More articles

Latest article